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Abstract
Purpose—Prevalence of visual impairment (VI) in the United States (US) has not been carefully
examined by race-ethnic subgroups. This study examines self-reported VI prevalence in race-
ethnic subgroups using data representative of the US population age ≥45 years.
Methods—The National Health Interview Survey (NHIS) is a population-based multipurpose
and multistage area probability annual survey of the US civilian non-institutionalized population
conducted by the National Center for Health Statistics. Data from a total of 122,649 participants
age ≥45 years from the pooled 1999–2006 National Health Interview Surveys was used; VI
prevalence was based on two questions asked to participants, “Do you have any trouble seeing,
even when wearing glasses or contact lenses?” (some VI), and “Are you blind or unable to see at
all?” (severe VI).
Results—For middle-aged adults age 45–64 years, race/ethnic groups with high age-adjusted
rates of any self-reported VI (some or severe VI) include Native Americans, Puerto Ricans,
Dominicans, and those reporting mixed race/ethnicity. Among older adults age ≥65 years,
understudied race/ethnic groups with high age-adjusted rates of any self-reported VI include
Native Americans, Chinese Americans, Puerto Ricans, Dominicans, Central/South Americans, and
those reporting mixed race/ethnicity. Among older adults with severe VI, race/ethnic groups with
VI prevalence include Filipino, Chinese Americans, Dominicans, Cubans, and Puerto Ricans and
those reporting mixed race/ethnicity.
Conclusions—Among understudied US race-ethnic groups, older Native Americans, Chinese
Americans, Puerto Ricans, Dominicans, and Central/South Americans generally have high rates of
self-reported VI suggesting further targeted epidemiologic and intervention studies may be
warranted.
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Visual impairment (VI) is a significant source of morbidity for the aging United States (US)
population and is associated with a range of adverse psychosocial outcomes including poor
functioning, lower quality of life and depression,1–3 increased injury and accident risk,4, 5
and reduced survival.1, 2, 6 The estimated annual total financial burden of major adult visual
disorders for the U.S. is $5 billion to $35 billion.7–9
The US population is becoming more diverse racially and ethnically, and several studies
have demonstrated differences in the prevalence of VI as well as the disparity of eye care
among some race-ethnic groups.10–13 However, population-based prevalence estimates of
VI have not been previously examined for small race-ethnic groups, particularly for older
adults. This study examines reported VI prevalence in small race-ethnic subgroups using
data representative of the US population aged 45 years and older. The study received
approval from the University of Miami Human Subjects Committee.
MATERIALS AND METHODS
The National Health Interview Survey (NHIS) is a continuous population-based
multipurpose and multistage area probability annual survey of the US civilian non-
institutionalized population conducted by the National Center for Health Statistics
(NCHS).14 The NHIS employs a complex sample survey design to obtain population-based
samples that are representative of the US civilian non-institutionalized population.
For the present analyses, complete VI and race-ethnic data were available on 122,649
participants of the 1999–2006 NHIS who were 45 years of age or older. During this period,
one adult from each household surveyed was randomly selected for the survey. Participants
were asked, “Do you have any trouble seeing, even when wearing glasses or contact
lenses?” (some VI), and “Are you blind or unable to see at all? (severe VI). Participants
were classified as “VI” if they responded yes to either question. The data were analyzed
using Statistical Analysis System (SAS)15 survey procedures to compute 1999–2006 pooled
VI prevalence adjusted for survey weights, design effects, and age.16 To account for the
aggregation of data over multiple survey years, these sample weights were modified by
dividing the annual weight by 8, the number of years combined; the sample weights used
were those required for the analysis of NHIS data from combined survey years and were
calculated as specified by Botman and Jack.17 For Age adjusted VI prevalence calculations,
the direct age adjustment method was used as specified by Klein and Schoenborn.16
RESULTS
Tables 1 to 4 present the 1999–2006 NHIS pooled self-reported VI prevalence rates for the
race-ethnic subgroups for adults aged 45–64 and aged ≥ 65. Table 1 displays the age-
adjusted prevalence of any VI (some or severe VI) by race and Hispanic subgroups. The
age-adjusted prevalence of any VI for all adults aged ≥ 65 years was 17.4% [95%
Confidence Interval 16.9–17.9]. All race and all ethnic subgroup prevalence rates are
significantly different from the corresponding survey prevalence rate and age-adjusted
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prevalence rate for whites and for non-Hispanics, respectively (p < 0.05). Those aged ≥ 65
years reporting more than one race designation (“multiple race”) had the highest age-
adjusted prevalence rate of any VI (25.5% [13.4–43.0]) followed by Native Americans
(25.1% [18.5–33.1]), African Americans (21.0% [19.5–22.6]), and Chinese (20.5% [14.0–
29.0]). Hispanic subgroups with rates of any VI higher than non-Hispanics included: those
reporting more than one Hispanic designation (40.0% [25.8–56.0]), Dominicans (23.6%
[16.5–32.5]), Puerto Ricans (22.9% [19.1–27.2]), Central/South Americans (20.6% [15.6–
26.7]), Mexican-Americans (19.2% [16.9–21.8]), and those reporting “other Hispanic”
designation (23.4% [17.2–31.0
Table 2 displays the pooled prevalence rates of some VI and severe VI among middle age
(45–64 years) and older (≥ 65 years) adults. Among older adults with severe VI, individuals
of multiple race (1.5% [0.4–6.1]), Chinese (1.4% [0.4–5.6]), and African Americans (1.2%
[0.9–1.6]) had the highest VI prevalence. Furthermore, among older adults with severe VI
with respect to Hispanic subgroups, Dominicans (3.7% [1.2–10.9]), Cubans (2.1% [0.8–
5.1]), Puerto Ricans (2.0% [1.2–3.3]), and those reporting “other Hispanic” designation
(3.3% [1.6–6.5]) had the highest VI prevalence.
The association between socio-demographics and some and severe VI by race are shown in
Table 3. Because of sample size limitations, individuals who are not white or not African
American were placed in the category of “all other”. Regardless of racial identity, the odds
of reporting some VI was significantly greater in females than in males (range of Odds Ratio
(OR) 1.21–1.28), even after adjusting for other demographics. However, female gender was
associated with lower odds of severe VI (range of ORs 0.53–0.88), but the association was
generally not significant. Higher education levels were associated with lower odds of some
VI in a dose-response fashion. Being insured, compared to uninsured, or married, compared
to not married, were found to be protective against some VI among whites and African
Americans. Among whites and blacks, greater educational attainment was also inversely
related to severe VI.
Table 4 shows the correlation between socio-demographics and VI by Hispanic subgroups.
Being female was associated with significantly greater odds of severe VI among Puerto
Ricans (OR 1.09 [1.06–1.12]) but significantly lower odds among Cuban Americans (OR
0.15 [0.11–0.22]). In general, greater educational attainment was associated with
significantly lower odds of self-reported VI.
DISCUSSION
Our results reveal up to 4-fold differences in self-reported age-group-specific VI rates
among race and ethnic subgroups. The results of our study are important to identify those
understudied race-ethnic groups with high self-reported VI who are likely in need of
improved eye care and health education. Similar to previous population-based studies,
African Americans and Mexican Americans were found to have high rates of VI compared
to whites and non-Hispanics (Table 1).13, 18, 19 This study expands on previous work to
highlight specific understudied race-ethnic groups with significantly higher prevalence of
any VI (some VI or severe VI) for both age 45–64 and ≥ 65 categories. These groups
Lam et al. Page 3






















include Native Americans (compared to whites) and Puerto Ricans and Dominicans
(compared to non-Hispanics). In addition, for participants aged ≥ 65 years, other groups
with significantly higher prevalence of VI include Chinese Americans, and Central or South
Americans. Reasons for disparities in the prevalence rates of self-reported VI among race-
ethnic subgroups may be related to a variety of factors including differences in ocular
structure.20, 21 differences in the prevalence of ocular diseases.13, 19, 22, 23, and disparities in
access to eye care.18, 24–29 Ocular epidemiologic and intervention studies targeting these
racial-ethnic groups with high prevalence of self-reported VI could potentially lead to
reductions in the VI prevalence disparities noted in this study. Of interest, those with self-
designated “multiple race” or “multiple Hispanics” also had significantly higher prevalence
of any VI for both age 45–64 and ≥ 65 categories. The reason for this finding is not clear,
and because these categories are heterogeneous race-ethnic groups, they would be difficult
to study epidemiologically or be targeted by interventional studies.
When further analysis were performed separately for some VI and severe VI, we found that,
among older adults aged ≥ 65 years with severe VI, individuals of multiple race, Filipino,
Chinese, and African Americans had the highest VI prevalence (Table 2), and among
Hispanic subgroups, Dominicans, Cubans, and Puerto Ricans had the highest severe VI
prevalence. These findings suggest further studies targeting the elderly in these race-ethnic
groups may be helpful to determine the need for intervention. Similar to previous studies of
VI19, 30, 31, we found the odds of reporting some VI was significantly greater in females
than in males, but the females in our study had lower odds of reporting severe VI than males
although this was generally not significant except for Cubans. Also similar to previous
studies of VI32–35, higher education, being insured, or married were associated with lower
odds of reporting VI.
Advantages of the NHIS include large sample size and the fact that NHIS is designed to be
representative of the US population, allowing for prevalence-estimation among small racial-
ethnic groups. Disadvantages of NHIS include self-reported measures of VI, likely resulting
in some misclassification of VI. To our knowledge, the specific visual impairment questions
employed in the NHIS have not been validated, although validation of similar questions
have been reported in the literature. For example, in one study, the specificity and sensitivity
of self-reported VI with clinical visual acuity measures as the ‘gold standard’ range from
82%–89%.36 In another study, the concordance of distance acuity results with the question
“Are you able to recognize a face from a distance of four meters” was reported to be 79%.37
However, the use of visual acuity as the ‘gold-standard’ or the only dimension of VI to
evaluate self-reported VI is subject to its own limitations given that other components of the
visual system can affect visual functioning. For instance, contrast sensitivity and
stereoacuity as well as visual acuity are independently associated with self-reported near and
far visual impairments in community-residing populations.38 In addition, visual acuity,
contrast and glare sensitivity, stereoacuity, and visual fields are significant independent risk
factors for self-reported visual disability in the elderly.39
In summary, in our analysis of older adults, we found high rates of self-reported VI several
understudied racial-ethnic groups such as Native Americans, Chinese Americans, Puerto
Ricans, Dominicans, Central/South Americans, and those with multiple race or Hispanic
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designations. This information has public health implications and is helpful to guide future
ocular epidemiologic and intervention studies.
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